参考文献/References:
[1]Siegel RL,Miller KD,Fuchs HE,et al.Cancer Statistics,2021[J].CA Cancer J Clin,2021,71(1):7-33.[2]Gray RE,Harris GT.Renal Cell Carcinoma: Diagnosis and Management[J].Am Fam Physician,2019,99(3):179-184. [3]Di Martino S,De Luca G,Grassi L,et al.Renal cancer: new models and approach for personalizing therapy[J].J Exp Clin Cancer Res,2018,37(1):217.[4]Makhov P,Joshi S,Ghatalia P,et al.Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma:Mechanisms and Management Strategies[J].Mol Cancer Ther,2018,17(7):1355-1364.[5]Gurram S,Al Harthy M,Ball MW.The changing landscape of systemic therapy in metastatic renal cell carcinoma: an update[J].Discov Med,2020,29(158):191-199. [6]Zhong M,Chen Z,Yan Y,et al.Expression of TIPE family members in human colorectal cancer[J].Oncol Lett,2021,21(2):118.[7]Gu Z,Cui X,Sun P,et al.Regulatory Roles of Tumor Necrosis Factor-α-Induced Protein 8 Like-Protein 2 in Inflammation, Immunity and Cancers: A Review[J].Cancer Manag Res,2020,12:12735-12746.[8]Shi B,Hao Y,Li W,et al.The enigmatic role of TIPE2 in asthma[J].Am J Physiol Lung Cell Mol Physiol,2020,319(1):L163-L172. [9]Li Z,Jia W,Niu J,et al.Understanding the roles of negative immune regulator TIPE2 in different diseases and tumourigenesis[J].Histol Histopathol,2018,33(9):919-928.[10]Ji J,Zhang YY,Fan YC.TIPE2 as a potential therapeutic target in chronic viral hepatitis[J].Expert Opin Ther Targets,2019,23(6):485-493.[11]Li XM,Su JR,Yan SP,et al.A novel inflammatory regulator TIPE2 inhibits TLR4-mediated development of colon cancer via caspase-8[J].Cancer Biomark,2014,14(4):233-240.[12]Bordoloi D,Banik K,Vikkurthi R,et al.Inflection of Akt/mTOR/STAT-3 cascade in TNF-α induced protein 8 mediated human lung carcinogenesis[J].Life Sci,2020,262:118475.[13]Zhang Z,Qi H,Hou S,et al.TIPE2 mRNA overexpression correlates with TNM staging in renal cell carcinoma tissues[J].Oncol Lett,2013,6(2):571-575.[14]Liu W,Fan Y,Shi Y,et al.Knockdown of TIPE2 increases the proliferation in lipopolysaccharide-stimulated gastric cancer cells[J].BMC Cancer,2018,18(1):857.[15]Li Y,Li X,Liu G,et al.Downregulated TIPE2 is associated with poor prognosis and promotes cell proliferation in non-small cell lung cancer[J].Biochem Biophys Res Commun,2015,457(1):43-49.[16]Chandrashekar DS,Bashel B,Balasubramanya SaH,et al.UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses[J].Neoplasia,2017,19(8):649-658.[17]Li X.TIPE2 regulates tumor-associated macrophages in skin squamous cell carcinoma[J].Tumour Biol,2016,37(4):5585-5590.[18]Bordoloi D,Banik K,Padmavathi G,et al.TIPE2 Induced the Proliferation, Survival, and Migration of Lung Cancer Cells Through Modulation of Akt/mTOR/NF-κB Signaling Cascade[J].Biomolecules,2019,9(12):836.[19]Lu Q,Liu Z,Li Z,et al.TIPE2 Overexpression Suppresses the Proliferation, Migration, and Invasion in Prostate Cancer Cells by Inhibiting PI3K/Akt Signaling Pathway[J].Oncol Res,2016,24(5):305-313.[20]Zhang Z,Liu L,Liu C,et al.TIPE2 suppresses the tumorigenesis, growth and metastasis of breast cancer via inhibition of the AKT and p38 signaling pathways[J].Oncol Rep,2016,36(6):3311-3316.[21]Zhu L,Zhang X,Fu X,et al.TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway[J].J Transl Med,2018,16(1):7.[22]Wu J,Zhang H,Xu C,et al.TIPE2 functions as a metastasis suppressor via negatively regulating β-catenin through activating GSK3β in gastric cancer[J].Int J Oncol,2016,48(1):199-206.[23]Ruan Q,Wang P,Wang T,et al.MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2[J].Cell Death Dis,2014,5(2):e1095.[24]Zhu Y,Tao M,Wu J,et al.Adenovirus-directed expression of TIPE2 suppresses gastric cancer growth via induction of apoptosis and inhibition of AKT and ERK1/2 signaling[J].Cancer Gene Ther,2016,23(4):98-106.[25]Liu ZJ,Liu HL,Zhou HC,et al.TIPE2 Inhibits Hypoxia-Induced Wnt/β-Catenin Pathway Activation and EMT in Glioma Cells[J].Oncol Res,2016,24(4):255-261.
相似文献/References:
[1]赵志廉,陆玲玲,郭 曼,等.育龄期女性乳腺癌中TIPE2的表达与VEGF、增殖能力的相关性分析[J].医学信息,2021,34(21):12.[doi:10.3969/j.issn.1006-1959.2021.21.003]
ZHAO Zhi-lian,LU Ling-ling,GUO Man,et al.Correlation Analysis of TIPE2 Expression with VEGF and Proliferation Ability in Women of Childbearing Age Breast Cancer[J].Journal of Medical Information,2021,34(04):12.[doi:10.3969/j.issn.1006-1959.2021.21.003]
[2]齐宏峰,刘金香,庞大斌,等.TIPE2、TGF-β1在非小细胞肺癌中的表达和意义[J].医学信息,2023,36(20):109.[doi:10.3969/j.issn.1006-1959.2023.20.020]
QI Hong-feng,LIU Jin-xiang,PANG Da-bin,et al.The Expression and Significance of TIPE2 and TGF-β1 in Non-small Cell Lung Cancer[J].Journal of Medical Information,2023,36(04):109.[doi:10.3969/j.issn.1006-1959.2023.20.020]
[3]柳旭丽,徐 红,刘金香,等.TIPE2、TNF-α、IL-1β在高血压脑出血患者的表达和意义[J].医学信息,2023,36(21):94.[doi:10.3969/j.issn.1006-1959.2023.21.021]
LIU Xu-li,XU Hong,LIU Jin-xiang,et al.Expression and Significance of TIPE2, TNF-α and IL-1β in Patients with Hypertensive Cerebral Hemorrhage[J].Journal of Medical Information,2023,36(04):94.[doi:10.3969/j.issn.1006-1959.2023.21.021]
[4]柳旭丽,徐 红,刘金香,等.TIPE2、TNF-α、MMP-22在冠心病的表达和意义[J].医学信息,2023,36(24):42.[doi:10.3969/j.issn.1006-1959.2023.24.007]
LIU Xu-li,XU Hong,LIU Jin-xiang,et al.Expression and Significance of TIPE2, TNF-α, MMP-22 in Coronary Heart Disease[J].Journal of Medical Information,2023,36(04):42.[doi:10.3969/j.issn.1006-1959.2023.24.007]